[Senate Prints 114-27]
[From the U.S. Government Publishing Office]







  
114th Congress   }                                       {    S. Prt.
                            COMMITTEE PRINT
 2nd Session     }                                       {     114-27                                 
______________________________________________________________________

                                     

 
                      HUMAN FETAL TISSUE RESEARCH:
                        CONTEXT AND CONTROVERSY

                               ----------                              

                         MAJORITY STAFF REPORT

                      PREPARED FOR THE USE OF THE

                       COMMITTEE ON THE JUDICIARY

                                     

                          UNITED STATES SENATE

                    ONE HUNDRED FOURTEENTH CONGRESS

                             SECOND SESSION



[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]



                             DECEMBER 2016


         Printed for the use of the Committee on the Judiciary



























  
114th Congress   }                                         {    S. Prt.
                            COMMITTEE PRINT
 2nd Session     }                                         {     114-27                                 
_______________________________________________________________________

                                     


                      HUMAN FETAL TISSUE RESEARCH:
                        CONTEXT AND CONTROVERSY

                               __________

                         MAJORITY STAFF REPORT

                      PREPARED FOR THE USE OF THE

                       COMMITTEE ON THE JUDICIARY

                                     

                          UNITED STATES SENATE

                    ONE HUNDRED FOURTEENTH CONGRESS

                             SECOND SESSION

[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]

                             DECEMBER 2016

         Printed for the use of the Committee on the Judiciary
         
                                   ______

                         U.S. GOVERNMENT PUBLISHING OFFICE 

22-920 PDF                     WASHINGTON : 2016 
-----------------------------------------------------------------------
  For sale by the Superintendent of Documents, U.S. Government Publishing 
  Office Internet: bookstore.gpo.gov Phone: toll free (866) 512-1800; 
         DC area (202) 512-1800 Fax: (202) 512-2104 Mail: Stop IDCC, 
                          Washington, DC 20402-0001         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
                       COMMITTEE ON THE JUDICIARY

                     CHUCK GRASSLEY, Iowa, Chairman
ORRIN G. HATCH, Utah                 PATRICK J. LEAHY, Vermont, Ranking 
JEFF SESSIONS, Alabama                   Member
LINDSEY GRAHAM, South Carolina       DIANNE FEINSTEIN, California
JOHN CORNYN, Texas                   CHUCK SCHUMER, New York
MICHAEL S. LEE, Utah                 DICK DURBIN, Illinois
TED CRUZ, Texas                      SHELDON WHITEHOUSE, Rhode Island
JEFF FLAKE, Arizona                  AMY KLOBUCHAR, Minnesota
DAVID VITTER, Louisiana              AL FRANKEN, Minnesota
DAVID PERDUE, Georgia                CHRISTOPHER A. COONS, Delaware
THOM TILLIS, North Carolina          RICHARD BLUMENTHAL, Connecticut

             Kolan Davis, Chief Counsel and Staff Director
      Kristine Lucius, Democratic Chief Counsel and Staff Director
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      

                            C O N T E N T S

                                                                   Page

Executive Summary................................................     1
 I. The Initial Public Debate About Fetal Tissue Research.............8
II. Congressional Response to the Fetal Research Debate..............10
III.The Return of the Fetal Tissue Debate in the Late 1980s..........12

    A. The Human Fetal Tissue Transplantation Research Panel.........12
    B. The George H.W. Bush Administration Rejects the Panel's
     Recommendations.................................................14
    C. Congressional Efforts To Overturn the Ban and Codify the Panel's
     Recommendations.................................................14
    D. President Clinton Lifts the Ban and Congress Codifies the 
    Panel's
     Recommendations.................................................16
IV. The NIH Revitalization Act of 1993...............................17
    A. The Terms of 42 U.S.C. Sec. 289g-1............................17
    B. The Terms of 42 U.S.C. Sec. 289g-2............................18
    C. GAO Verification Report.......................................19
    D. Proposed Modification of 42 U.S.C.Sec. 289g-2 To Require 
    Reporting........................................................20
 V. Media and Congressional Investigations Into Violations of 42 
    U.S.C.Sec. 289g-2  in the Year 2000..............................22
    A. Call for Congressional Investigation..........................22
    B. 20/20 Hidden-Camera Fetal Tissue Investigation................22
    C. Hearing by the House Subcommittee on Health...................23
    D. Another Proposed Modification of 42 U.S.C. Sec. 289g-2 To 
    Require
     Reporting.......................................................26
    E. 2000 GAO Report on Fetal Tissue Research......................26
    F. Summary.......................................................27
VI. The Recent Controversy...........................................28
    A. The Scope of the Committee's Investigation....................29
      1. Laws Potentially Violated or in Need of Modification........29
      2. Parties Involved............................................29
    B. Advanced Bioscience Resources, Inc............................30
      1. Contracts With Planned Parenthood Affiliates................31
      2. ABR's Fetal Tissue Technicians..............................33
      3. Contracts With ABR's Customers..............................34
      4. Fetal Tissue Transaction Examples...........................35
      5. ABR's Purported Cost Justification..........................38
    C. StemExpress, LLC..............................................39
      1. Contracts With Planned Parenthood Affiliates................40
      2. StemExpress's Payments to Its Technicians...................41
      3. Example of a StemExpress Fetal Tissue Transaction...........42
      4. StemExpress's Purported Cost Justification..................42
    D. Novogenix Laboratories, LLC...................................43
    E. Planned Parenthood............................................44
      1. PPFA's 2001 Fetal Tissue Policy.............................46
      2. Developments in 2011........................................47
      3. PPFA Stops Monitoring Affiliate Fetal Tissue Programs in
    Accreditation Reviews............................................48
      4. Policy Changes in May 2015..................................50
      5. Planned Parenthood's Post Hoc Cost Calculations Created in
    Response to the Committee's Inquiry..............................51
    F. Continued Lack of Oversight and Enforcement...................53
VII. Conclusion..................................................    54
Note Regarding Exhibits..........................................    64
Combined Exhibits................................................    65
Appendix I.......................................................   308
Appendix II......................................................   403
Appendix III.....................................................   459

                  [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]


                                 [all]